Literature DB >> 19479196

[Correlation of depression with stroke. Pathophysiological mechanisms].

P Neu1.   

Abstract

Stroke is the third leading cause of death, just after heart disease and cancer. Its incidence will probably increase dramatically in the coming decades. For prevention it is urgently necessary to gain fundamental knowledge about the risk factors and pathophysiological mechanisms. It is now widely accepted that depression and stroke are correlated with each other. There is little knowledge, however, about the links that might connect both diseases. This review discusses different mechanisms that lead to an increased stroke risk and can be influenced by depression as well thus possibly linking depression and stroke.

Entities:  

Mesh:

Year:  2009        PMID: 19479196     DOI: 10.1007/s00115-009-2720-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  66 in total

1.  Cerebrovascular reactivity in depressed patients without vascular risk factors.

Authors:  A Gómez-Carrillo de Castro; M Bajbouj; P Schlattmann; H Lemke; I Heuser; P Neu
Journal:  J Psychiatr Res       Date:  2006-11-20       Impact factor: 4.791

Review 2.  Endothelial influences on cerebrovascular tone.

Authors:  Jon Andresen; Nadeem I Shafi; Robert M Bryan
Journal:  J Appl Physiol (1985)       Date:  2006-01

Review 3.  The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.

Authors:  Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

4.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

5.  Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.

Authors:  Michael F Nielsen; Andrea Caumo; Visvanathan Chandramouli; William C Schumann; Claudio Cobelli; Bernard R Landau; Hendrik Vilstrup; Robert A Rizza; Ole Schmitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-09-09       Impact factor: 4.310

6.  Salivary cortisol is related to atherosclerosis of carotid arteries.

Authors:  M J H J Dekker; J W Koper; M O van Aken; H A P Pols; A Hofman; F H de Jong; C Kirschbaum; J C M Witteman; S W J Lamberts; H Tiemeier
Journal:  J Clin Endocrinol Metab       Date:  2008-08-05       Impact factor: 5.958

7.  Depressive symptomatology and hypertension-associated morbidity and mortality in older adults.

Authors:  E M Simonsick; R B Wallace; D G Blazer; L F Berkman
Journal:  Psychosom Med       Date:  1995 Sep-Oct       Impact factor: 4.312

8.  Increased stroke risk predicted by compromised cerebral blood flow reactivity.

Authors:  H Yonas; H A Smith; S R Durham; S L Pentheny; D W Johnson
Journal:  J Neurosurg       Date:  1993-10       Impact factor: 5.115

9.  Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients.

Authors:  D F Nugent; T G Dinan; B E Leonard
Journal:  J Affect Disord       Date:  1995-04-04       Impact factor: 4.839

Review 10.  The HPA axis in major depression: classical theories and new developments.

Authors:  Carmine M Pariante; Stafford L Lightman
Journal:  Trends Neurosci       Date:  2008-07-31       Impact factor: 13.837

View more
  2 in total

Review 1.  Depressive syndromes in neurological disorders.

Authors:  Julian Hellmann-Regen; Dominique Piber; Kim Hinkelmann; Stefan M Gold; Christoph Heesen; Carsten Spitzer; Matthias Endres; Christian Otte
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11       Impact factor: 5.270

Review 2.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.